Market Overview:
The global biochip market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for biochips from biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, and other end users. Additionally, the growing focus on personalized medicine is also contributing to the growth of the global biochip market. Microarrays are expected to account for the largest share of the global biochip market in 2018. This can be attributed to their high adoption rate across various applications such as drug discovery & development, biomarker identification & validation, target identification & validation, and others.
Product Definition:
A biochip is a device that integrates one or more microchips with biological molecules, such as DNA, proteins, or cells. Biochips are used for many purposes including research and diagnostics.
Microarrays:
Microarrays is a technology that involves the use of small pieces of DNA, RNA or protein molecules as probes to identify and measure the expression of genes. It has been used in various applications such as gene mapping, gene expression profiling and biomarker discovery. The technique allows for rapid scanning through large numbers of genes at high speed which helps in faster diagnosis & research.
Microfluidics:
Microfluidics is the study of fluid motion at the molecular scale. It includes a wide range of techniques that are based on principles derived from micro-physics, microbiology, and chemistry. Microfluidics has been applied in research and development for many years; however, it has only recently begun to be used on a commercial level.
Application Insights:
The other end-use applications include biochip manufacturers themselves using their chips for research and development purposes. The application segment is segregated into five sub-segments, namely biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, other end-users including food safety testing laboratories.
Pharmaceutical companies were the largest application sector of the global biochip market in 2017 owing to increasing R&D investments by pharmaceutical companies for developing new medicines using advanced biochips technology. For instance, in March 2018 Merck KGaA announced about its plan to invest ¢â€š¹60 million (USD 744 thousand) over 3 years for discovering potential drug candidates from a genetic standpoint through integrated genomic analysis of human cells & genes.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and pharmaceutical companies, which are among the early adopters of advanced technologies, is expected to drive this regional market over the forecast period. Furthermore, increasing investments in R&D by these companies coupled with government support for higher education and healthcare research is anticipated to fuel growth during the forecast period.
Asia Pacific region is projected to witness lucrative growth over the next eight years owing to rapid developments witnessed in several emerging economies such as China and India. In addition, favorable government initiatives pertaining to increased funding for life science-related research are expected drive this regional market during the forecast period.
Growth Factors:
- Increasing demand for biochips in the field of diagnostics and personalized medicine.
- Rising prevalence of chronic diseases that can be effectively managed with the help of biochips.
- Growing application areas for biochips such as drug discovery, genomics, proteomics, and diagnostics.
- Technological advancements in the field of biochip manufacturing that are making them more efficient and affordable.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biochip Market Research Report
By Type
Microarrays, Microfluidics
By Application
Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Other End Users
By Companies
Abbott Laboratories, PerkinElmer, Inc, GE Healthcare, Sigma-Aldrich Corporation, Agilent Technologies, Inc, Illumina, Inc., Bio-Rad Laboratories, Fluidigm Corporation, Thermo Fisher Scientific, Merck Millipore, Abbott Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Biochip Market Report Segments:
The global Biochip market is segmented on the basis of:
Types
Microarrays, Microfluidics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Other End Users
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- PerkinElmer, Inc
- GE Healthcare
- Sigma-Aldrich Corporation
- Agilent Technologies, Inc
- Illumina, Inc.
- Bio-Rad Laboratories
- Fluidigm Corporation
- Thermo Fisher Scientific
- Merck Millipore
- Abbott Laboratories
Highlights of The Biochip Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microarrays
- Microfluidics
- By Application:
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostics Centers
- Academic & Research Institutes
- Other End Users
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biochip Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A biochip is a small, thin device that can be inserted under the skin to measure various health indicators. Biochips are often used in medical research and to track the health of patients.
Some of the major companies in the biochip market are Abbott Laboratories, PerkinElmer, Inc, GE Healthcare, Sigma-Aldrich Corporation, Agilent Technologies, Inc, Illumina, Inc., Bio-Rad Laboratories, Fluidigm Corporation, Thermo Fisher Scientific, Merck Millipore, Abbott Laboratories.
The biochip market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biochip Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biochip Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biochip Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biochip Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biochip Market Size & Forecast, 2020-2028
4.5.1 Biochip Market Size and Y-o-Y Growth
4.5.2 Biochip Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Microarrays
5.2.2 Microfluidics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Biotechnology and Pharmaceutical Companies
6.2.2 Hospitals and Diagnostics Centers
6.2.3 Academic & Research Institutes
6.2.4 Other End Users
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biochip Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biochip Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Microarrays
9.6.2 Microfluidics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Biotechnology and Pharmaceutical Companies
9.10.2 Hospitals and Diagnostics Centers
9.10.3 Academic & Research Institutes
9.10.4 Other End Users
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Microarrays
10.6.2 Microfluidics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Biotechnology and Pharmaceutical Companies
10.10.2 Hospitals and Diagnostics Centers
10.10.3 Academic & Research Institutes
10.10.4 Other End Users
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Microarrays
11.6.2 Microfluidics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Biotechnology and Pharmaceutical Companies
11.10.2 Hospitals and Diagnostics Centers
11.10.3 Academic & Research Institutes
11.10.4 Other End Users
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Microarrays
12.6.2 Microfluidics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Biotechnology and Pharmaceutical Companies
12.10.2 Hospitals and Diagnostics Centers
12.10.3 Academic & Research Institutes
12.10.4 Other End Users
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Microarrays
13.6.2 Microfluidics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Biotechnology and Pharmaceutical Companies
13.10.2 Hospitals and Diagnostics Centers
13.10.3 Academic & Research Institutes
13.10.4 Other End Users
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biochip Market: Competitive Dashboard
14.2 Global Biochip Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 PerkinElmer, Inc
14.3.3 GE Healthcare
14.3.4 Sigma-Aldrich Corporation
14.3.5 Agilent Technologies, Inc
14.3.6 Illumina, Inc.
14.3.7 Bio-Rad Laboratories
14.3.8 Fluidigm Corporation
14.3.9 Thermo Fisher Scientific
14.3.10 Merck Millipore
14.3.11 Abbott Laboratories
